Literature DB >> 28663714

Biodegradable seeds of holmium don't change neurological function after implant in brain of rats.

Mirla Fiuza Diniz1, Diogo Milioli Ferreira1, Wanderson Geraldo de Lima2, Maria Lucia Pedrosa2, Marcelo Eustáquio Silva3, Stanley de Almeida Araujo1, Kinulpe Honorato Sampaio4, Tarcisio Passos Ribeiro de Campos5, Savio Lana Siqueira1.   

Abstract

AIM: To evaluate the surgical procedure and parenchymal abnormalities related to implantation of ceramic seeds with holmium-165 in rats' brain.
BACKGROUND: An effective method of cancer treatment is brachytherapy in which radioactive seeds are implanted in the tumor, generating a high local dose of ionizing radiation that can eliminate tumor cells while protecting the surrounding healthy tissue. Biodegradable Ho166-ceramic-seeds have been addressed recently. METHODS AND MATERIALS: The experiments in this study were approved by the Ethics Committee on Animal Use at the Federal University of Ouro Preto, protocol number 2012/034. Twenty-one adult Fischer rats were divided into Naive Group, Sham Group and Group for seed implants (ISH). Surgical procedures for implantation of biodegradable seeds were done and 30 days after the implant radiographic examination and biopsy of the brain were performed. Neurological assays were also accomplished to exclude any injury resulting from either surgery or implantation of the seeds.
RESULTS: Radiographic examination confirmed the location of the seeds in the brain. Neurological assays showed animals with regular spontaneous activity. The histological analysis showed an increase of inflammatory cells in the brain of the ISH group. Electron microscopy evidenced cytoplasmic organelles to be unchanged. Biochemical analyzes indicate there was neither oxidative stress nor oxidative damage in the ISH brain. CAT activity showed no difference between the groups as well as lipid peroxidation measured by TBARS.
CONCLUSIONS: The analysis of the data pointed out that the performed procedure is safe as no animal showed alterations of the neurological parameters and the seeds did not promote histological architectural changes in the brain tissue.

Entities:  

Keywords:  Brachytherapy; Brain; Holmium; Morphometry; Seeds; Tumor

Year:  2017        PMID: 28663714      PMCID: PMC5472264          DOI: 10.1016/j.rpor.2017.03.003

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  25 in total

1.  Neurocognitive function and quality of life in patients with newly diagnosed brain metastasis after treatment with intra-operative cesium-131 brachytherapy: a prospective trial.

Authors:  Anthony Pham; Menachem Z Yondorf; Bhupesh Parashar; Ronald J Scheff; Susan C Pannullo; Rohan Ramakrishna; Philip E Stieg; Theodore H Schwartz; A Gabriella Wernicke
Journal:  J Neurooncol       Date:  2015-12-09       Impact factor: 4.130

Review 2.  Biomaterials: a forecast for the future.

Authors:  L L Hench
Journal:  Biomaterials       Date:  1998-08       Impact factor: 12.479

3.  Catalase in vitro.

Authors:  H Aebi
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

4.  Microbrachytherapy using holmium-166 acetylacetonate microspheres: a pilot study in a spontaneous cancer animal model.

Authors:  Wouter Bult; Maarten A D Vente; Eva Vandermeulen; Ingrid Gielen; Peter R Seevinck; Jimmy Saunders; Alfred D van Het Schip; Chris J G Bakker; Gerard C Krijger; Kathelijne Peremans; Johannes F W Nijsen
Journal:  Brachytherapy       Date:  2012-09-19       Impact factor: 2.362

5.  A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model.

Authors:  Takashi Sugawara; Robert Ayer; Vikram Jadhav; John H Zhang
Journal:  J Neurosci Methods       Date:  2007-08-12       Impact factor: 2.390

6.  Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation.

Authors:  J H Garcia; S Wagner; K F Liu; X J Hu
Journal:  Stroke       Date:  1995-04       Impact factor: 7.914

7.  Neurovascular protection reduces early brain injury after subarachnoid hemorrhage.

Authors:  S Park; M Yamaguchi; C Zhou; J W Calvert; J Tang; John H Zhang
Journal:  Stroke       Date:  2004-08-19       Impact factor: 7.914

8.  Behavioral deficits following experimental subarachnoid hemorrhage in the rat.

Authors:  A F Germanò; C E Dixon; D d'Avella; R L Hayes; F Tomasello
Journal:  J Neurotrauma       Date:  1994-06       Impact factor: 5.269

9.  Interstitial brachytherapy as boost for locally advanced T4 head and neck cancer.

Authors:  Ly Do; Ajmel Puthawala; Nisar Syed
Journal:  Brachytherapy       Date:  2009-09-03       Impact factor: 2.362

Review 10.  Brachytherapy: state of the art and possible improvements.

Authors:  S Buono; N Burgio; M Hamoudeh; H Fessi; E Hiltbrand; L Maciocco; S Mehier-Humbert
Journal:  Anticancer Agents Med Chem       Date:  2007-07       Impact factor: 2.505

View more
  1 in total

Review 1.  The various therapeutic applications of the medical isotope holmium-166: a narrative review.

Authors:  Nienke J M Klaassen; Mark J Arntz; Alexandra Gil Arranja; Joey Roosen; J Frank W Nijsen
Journal:  EJNMMI Radiopharm Chem       Date:  2019-08-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.